Preclinical models for development of immune–oncology therapies

Y Wang, S E Shelton, G Kastrunes et al

27 September 2022

Expert Insight

Control of continuous processes for production of biopharmaceutical products

Anurag Rathore, Saxena Nikita

29 November 2021

Expert Insight

The use of artificial intelligence in immuno-oncology drug discovery: are we closing the gap?

Carlo Boutton, Maria Wendt

08 October 2021

Expert Insight

Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing

Michael Pawlak, Markus Templin, Christian Schmees

05 August 2021

Expert Insight

Digital pathology for the identification of prognostic biomarkers in head and neck cancer

Rasha Abu-Eid, Frank James Ward

08 June 2021

Expert Insight